Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of Qualia NAD+ Supplementation on Intracellular NAD Levels: A Double-Blind Parallel Trial

NCT06812416 is registered in ClinicalTrials.gov with Qualia Life Sciences as lead sponsor.

NCT NCT06812416
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06812416 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of Qualia NAD+ Supplementation on Intracellular NAD Levels: A Double-Blind Parallel Trial
Lead sponsor
Qualia Life Sciences
Phase
Not applicable
Overall status
Completed
Start date
October 24, 2023
Completion date
March 11, 2024
Enrollment
92 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

intracellular nad+ levels